Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
4,591 people get CVS articles and Market Currents by email alert.
Get email alerts on CVS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Aetna Appears UndervaluedDoctoRx • Thu, May 16 -
PR Newswire (Tue, 12:00PM)
-
PR Newswire (Tue, 8:30AM)
-
PR Newswire (Mon, 5:18PM)
-
-
-
PR Newswire (May 9, 2013)
-
-
-
PR Newswire (May 1, 2013)
-
-
PR Newswire (Apr 30, 2013)
-
Regulation To Drive Pharmacy SpecializationTom Luongo • Fri, Apr 26 -
-
PR Newswire (Apr 19, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
Why We Like CVS CaremarkUlfberht Capital • Mon, Apr 8 -
-
-
-
-
-
-
-
-
-
Earnings Analysis: CVS CaremarkCapitalCube • Wed, Nov 7, 2012 -
Watch For Walgreen-Express Scripts Impact In CVS Caremark EarningsTrefis • Mon, Nov 5, 2012
-
-
-
-
-
CVS: Demographics And Business Model Mean Tons Of Upside For The StockMike Williams • Thu, Aug 16, 2012
-
-
Aetna Appears UndervaluedDoctoRx • Thu, May 16
-
-
-
Regulation To Drive Pharmacy SpecializationTom Luongo • Fri, Apr 26
-
-
-
-
-
-
-
Dollar General: Full Steam Ahead?Black Coral Research • Mon, Apr 8 -
-
-
-
-
-
-
-
-
CVS Caremark's CEO Hosts 2012 Analyst Day (Transcript)Thu, Dec 13, 2012
-
CVS Caremark's CEO Discusses Q4 2011 Results - Earnings Call TranscriptWed, Feb 8, 2012 • 1 Comment
-
CVS Caremark Corporation - Analyst/Investor DayTue, Dec 20, 2011
-
CVS Caremark's CEO Discusses Q3 2011 Results - Earnings Call TranscriptThu, Nov 3, 2011 • 1 Comment
-
CVS Caremark Corporation Q2 2010 Earnings Call TranscriptThu, Jul 29, 2010
-
CVS Caremark Q1 2010 Earnings Call TranscriptTue, May 4, 2010
-
CVS Caremark Corporation Q4 2009 Earnings Call TranscriptMon, Feb 8, 2010
-
CVS Caremark Q3 2009 Earnings Call TranscriptThu, Nov 5, 2009
-
CVS Caremark Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
CVS Caremark Corporation Q1 2009 Earnings Call TranscriptTue, May 5, 2009
-
CVS Caremark Corporation Q4 2008 Earnings Call TranscriptThu, Feb 19, 2009
-
PR Newswire (Tue, 12:00PM)
-
PR Newswire (Tue, 8:30AM)
-
PR Newswire (Mon, 5:18PM)
-
at Fox Business (Mon, 9:10AM)
-
PR Newswire (May 9, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
at Fox Business (May 1, 2013)
-
at CNBC.com (May 1, 2013)
-
PR Newswire (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
PR Newswire (Apr 30, 2013)
-
at MarketWatch.com (Apr 28, 2013)
-
at CNBC.com (Apr 26, 2013)
-
at CNBC.com (Apr 20, 2013)
-
PR Newswire (Apr 19, 2013)
CVS vs. ETF Alternatives
Company Description
CVS Caremark Corporation (“CVS Caremark”, the “Company”, “we” or “us”) is the largest pharmacy health care provider in the United States. As a fully integrated pharmacy services company, we believe we can drive value for our customers by effectively managing pharmaceutical costs and improving... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, May 6, 9:23 AM Pfizer (PFE) plans to start selling Viagra online, according to an AP report. The initiative could serve as a test run by Big Pharma over disrupting its current model to look at online distribution for treatments viewed as more embarrassing to buy in person. Drugstore operators (CVS, WAG, RAD) will be watching the development very carefully. PFE -0.1% premarket. 2 Comments [Healthcare, Consumer]
- Wednesday, May 1, 7:26 AM More on CVS Caremark's (CVS) Q1: The drugstore operator reports a mild Y/Y gain in revenue with volume increases and drug cost inflation helping to offset the impact of new generic introductions. Pharmacy network claims increased 4.3% to 207.1M. The company sees 2013 EPS of $3.89-$4.00 vs. consensus $3.96. (PR) Comment! [Consumer, Earnings]
- Wednesday, May 1, 7:05 AM CVS Caremark (CVS): Q1 EPS of $0.83 beats by $0.03. Revenue of $30.7B beats by $0.34B. (PR) Comment! [Earnings, Breaking News]
- Wednesday, May 1, 12:05 AM Notable earnings before Wednesday’ s open: AB, ADT, AFAM, AFSI, AGN, AH, AMT, ARW, AVA, CCJ, CHK, CLH, CLX, CMCSA, CVH, CVS, DLPH, DVN, ENR, EXAS, EXC,GRMN, GWR, H, HSP, HUM, ICE, IPGP, IQNT, IRM, JRCC, KCG, KFN, MA, MKL, MRK, NVO, PDCE, PKD, POR, PSX, RDC, RDN, SEE, SPW, TLM, TWX, VG, VIAB, VPHM Comment! [Earnings]
- Tuesday, April 30, 5:30 PM Notable earnings before Wednesday’ s open: AB, ADT, AFAM, AFSI, AGN, AH, AMT, ARW, AVA, CCJ, CHK, CLH, CLX, CMCSA, CVH, CVS, DLPH, DVN, ENR, EXAS, EXC,GRMN, GWR, H, HSP, HUM, ICE, IPGP, IQNT, IRM, JRCC, KCG, KFN, MA, MKL, MRK, NVO, PDCE, PKD, POR, PSX, RDC, RDN, SEE, SPW, TLM, TWX, VG, VIAB, VPHM Comment! [Earnings]
- Tuesday, April 30, 10:04 AM A combined read of Redbook and ICSCS-Goldman's data on chain store sales indicates the late start to the spring season could take its toll on apparel sellers. Despite the choppy start to Q2, chain-store sales are still heading for a 2%-3% gain during the month compared to last year. Possible April winners: Drugstores [Walgreen (WAG), Rite Aid (RAD), CVS Caremark (CVS)] and wholesale clubs [Costco (COST), PriceSmart (PSMT), BJ's Wholesale]. Comment! [Consumer, U.S. Economy]
- Sunday, April 7, 9:00 AM With their healthcare costs ballooning, many companies have started to penalize fat employees with regards to healthcare coverage, raising all sorts of legal, privacy and discrimination questions. Michelin North America, for example, plans to cut healthcare credits for staff who fail to meet requirement for waistline and other metrics, and don't sign up to health programs. Other companies making similar moves include Mohawk (MHK), CVS and Honeywell (HON). 60 Comments [Healthcare, Consumer]
- Thursday, April 4, 12:51 PM Health experts forecast this season's allergy season will be extremely harsh. As a result, drug store chains such as Rite Aid (RAD -3.7%), CVS Caremark (CVS +1.9%), and Walgreen (WAG +0.4%) are expecting a mild bounce in April store traffic due to the development. (Previous on March sales: WAG, RAD) Comment! [Consumer]
- Thursday, March 28, 9:18 AM Look for a new report from Consumer Reports on the cost of prescription drugs at retail chains to create some buzz. Analysis by the publication shows that consumers can save as much as $100 a month by comparison shopping. Costco (COST) came in the low end of the scale for generic drug prices while CVS Caremark (CVS) was the highest. Drugstore chains (WAG, RAD) could face increasing pricing pressure with big box retailers more willing to use low prices at their pharmacies as a traffic driver. 4 Comments [Consumer, Healthcare]
- Wednesday, March 6, 3:47 PM CVS Caremark Corporation (CVS) declares $0.225/share quarterly dividend, in line with previous. Forward yield 1.72%. For shareholders of record Apr. 23. Payable May 03. Ex-div date Apr. 19. (PR) Comment! [Dividends]
- Friday, March 1, 7:14 AM Drugstore chains (WAG, CVS, RAD) continue to push further into healthcare to make up for lagging prescription drug sales. The latest development is an initiative by Rite Aid to open 58 stores which have in-store clinics where customers can interact with a doctor using a Web cam. Customers in Baltimore, Boston, Philadelphia, and Pittsburgh can pay $45 for a 10-minute consult with a doctor via a PC. 6 Comments [Consumer, Healthcare]
- Tuesday, February 19, 12:37 PM CVS Caremark (CVS +2.6%) and Rite Aid (RAD +5.4%) both trade higher, riding the back of a strong quarter and promising guidance from Express Scripts. Sector peer Walgreen (WAG +0.9%) isn't quite keeping up despite a price target boost by Cantor Fitzgerald to $45. 2 Comments [Consumer, On the Move]
- Monday, February 11, 2:21 PM After seeing the number of flu shots administered skyrocket this year to boost revenue, drug store operators such as Walgreen (WAG +0.1%) and CVS Caremark (CVS +0.1%) want to expand past flu shots to offer a full range of immunizations and additional healthcare services. For the sector to gets its way, states will have to expand the powers of pharmacists, a development that stands a decent chance of coming off because it saves employers money. 1 Comment [Consumer]
- Wednesday, February 6, 7:18 AM More on CVS Caremark's (CVS) Q4: Revenue in the Retail Pharmacy segment rose 5.1% to $16.3B as higher traffic more than offset the impact of new generic introductions. An effective tax rate and share count that were lower than anticipated contributed to the EPS beat. The company sees FY13 EPS of $3.86-$4.00, roughly in-line with the consensus estimate of analysts calling for $3.94. (PR) Comment! [Earnings, Consumer]
- Wednesday, February 6, 7:01 AM CVS Caremark (CVS): Q4 EPS of $1.14 beats by $0.03. Revenue of $31.4B (+10.9% Y/Y) beats by $0.27B. (PR) Comment! [Earnings, Breaking News]
- Wednesday, February 6, 12:05 AM Notable earnings before Wednesday’s open: ABMD, AINV, CMI, CMP, CVH, CVS, ELN, GAS, ICE, IVR, MPEL, MRO, MT, NUS, PLD, RL, TWX, USG, VICL, VMED Comment! [Earnings]
-
- View all 0 replies
-
- View all 1 replies
-
-
- View all 2 replies
-
-
Nefas: nice one...i have to trim my portfolio..some positions are rly hard to handle
-
- View all 7 replies
-
Ocean Man: Just kidding. It's good long term, but I sometimes take gains on quick pops too, look to get back in lower.
-
jmok322: no worries - sorry thought you may have been adding to already existing positions
-
- View all 0 replies
-
Brian Nichols
I've been saying since $1.20, if $RAD is profitable it's going to $5. Deep discount to $WAG and $CVS - View all 1 replies
-
ps677: Customer don't care what price RAD is selling for but RAD does "look" like Dollar Tree turned pharmacy shop. Good deal on Hineken beer.
-
Paul Zimbardo
Quality Dividends To Consider and Avoid http://seekingalpha.com/a/sqd9 $CL $CVS $CXW $MAIN $SNH #Stocks #Dividends #News #Investing #CVS - View all 0 replies
-
Tony Kau
$CVS plateauing again? looks like it... #getyourswingtradeon http://ow.ly/jTGXe http://ow.ly/i/1R4gY - View all 0 replies
-
- View all 3 replies
-
Tony Kau: We used to give that horse medicine to our dog growing up (at least it had a pic of a horse on it) - Scamp is 9, so it's probably time?
-
Perkins Cove: His hips will love you. We dogs must stick together..... [IMG]http://bit.ly/WBw2Bw[/IMG]
-
- View all 0 replies
LATEST REPLIES
-
- View all 1 replies
-
-
- View all 2 replies
-
-
Nefas: nice one...i have to trim my portfolio..some positions are rly hard to handle
-
- View all 7 replies
-
Ocean Man: Just kidding. It's good long term, but I sometimes take gains on quick pops too, look to get back in lower.
-
jmok322: no worries - sorry thought you may have been adding to already existing positions
-
Brian Nichols
I've been saying since $1.20, if $RAD is profitable it's going to $5. Deep discount to $WAG and $CVS - View all 1 replies
-
ps677: Customer don't care what price RAD is selling for but RAD does "look" like Dollar Tree turned pharmacy shop. Good deal on Hineken beer.
-
- View all 3 replies
-
Tony Kau: We used to give that horse medicine to our dog growing up (at least it had a pic of a horse on it) - Scamp is 9, so it's probably time?
-
Perkins Cove: His hips will love you. We dogs must stick together..... [IMG]http://bit.ly/WBw2Bw[/IMG]
-
Ocean Man
Sold $CVS for a gain of 2.3% in 2 days. $50.34 ---> $51.50. http://seekingalpha.com/s/c8h8v - View all 16 replies
-
Perkins Cove: "got' it OM......so, you were up over 20%, with a 35 horse stable earlier this month. Safe to say you have kept your gains...?
-
-
ConservativeOutperformer
Very clean presentation by $CVS this morning. Breaking out the cash available to owners and goals for operations = Winning! - View all 1 replies
-
ConservativeOutperformer: Slide 16 of their Analyst Presentation is showing $22.5B in cash available for returns from '13 to '15. Thats, >33% the current mkt cap.
-
- View all 1 replies
-
-
- View all 3 replies
-
-
-
- View all 2 replies
-
Chines33: I think it goes to 50-52. Strong dollar aging population I the sweet spot
-
-
- View all 1 replies
-
-
- View all 3 replies
-
-
vinyal: we should break support by friday of 1292. Sell all rallies. Hedge your longs
-
- View all 2 replies
-
-
-
Hillbilly Stock Star
CVS, WAG,........radar watch, moving into "dollar store" type items, interesting. No current positions yet may nibble. - View all 1 replies
-
-
Alex Rasmussen
RAD is getting beaten up and for good reason. No earnings, lots of debt, and not big enough to add value for WAG or CVS. It sucks - View all 1 replies
-
